Purchase Order HT941023P0180

Award Date 9/20/23
Potential Completion Date 10/1/23
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Emigration Canyon, UT 84108, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Health Agency (DHA) awarded a firm-fixed-price delivery order contract to Biomerieux Inc., a global leader in in vitro diagnostics, for the provision of a microbiology analyzer and consumables. The $87,980.77 contract has an ultimate completion date of December 16, 2022. Biomerieux Inc., through its Biomerieux, Inc. division, is the sole awardee and is not subject to any set-aside designations. The company is known for its proprietary diagnostic platforms, such as VITEK,...
This firm-fixed-price purchase order was awarded by the National Institutes of Health (NIH) Clinical Center to Biomerieux Inc., a global leader in in vitro diagnostics, for the provision of bioscience equipment and consumables. The $6,420.31 contract provides Biomerieux's proprietary VITEK, BioFire, and VIDAS diagnostic platforms and associated test kits to support infectious disease testing and pathogen detection across government healthcare operations. Biomerieux holds several significant...
This is a federal contract awarded by the Defense Health Agency (DHA) to Biomerieux Inc., a global leader in in vitro diagnostics, for the delivery of reagents, materials, and test supplies. The $15,370.43 firm-fixed-price contract has an ultimate completion date of October 15, 2024. Biomerieux Inc., through its Biomerieux, Inc. division, provides a wide range of clinical diagnostic equipment, reagents, and supplies to various federal agencies, including the Departments of Veterans Affairs,...
This firm-fixed-price purchase order was awarded by the Defense Health Agency (DHA) to Biomerieux Inc., a global leader in in vitro diagnostics, for the provision of a VITEK 2 COMPACT 30 automated microbial identification system. The $56,625.00 contract has a completion date of September 30, 2022 and does not involve any set-aside designation. Biomerieux, through its Biomerieux, Inc. Division, is the prime contractor and manufacturer of the supplied equipment. This award is likely part of...
The U.S. Department of Veterans Affairs (VA) awarded a firm-fixed-price delivery order contract worth $29,559.00 to Biomerieux Inc. for automated blood culture testing equipment and supplies. The contract has a period of performance through June 3, 2025. Biomerieux Inc., a global leader in in vitro diagnostics, is providing its proprietary VITEK, BioFire, and VIDAS platforms and associated consumable products to support infectious disease testing and pathogen detection across VA healthcare...
The U.S. Defense Health Agency awarded a firm-fixed-price purchase order contract to Biomerieux Inc., a global leader in in vitro diagnostics, for the supply of VITEK 2 reagents and consumables. The contract, valued at $98,916.95, has an ultimate completion date of September 30, 2026. This contract does not have a set-aside designation. Biomerieux Inc., through its Biomerieux, Inc. Division, is a manufacturer of specialized medical diagnostic equipment, reagents, and supplies. The company has...
This firm-fixed-price purchase order was awarded to Biomerieux Inc., a global leader in in vitro diagnostics, to provide cost-per-test blood culture services to the Veterans Integrated Service Network 7 (VISN 7) of the U.S. Department of Veterans Affairs. The contract has a ceiling value of $22,680.00 and a period of performance through June 14, 2024. Biomerieux, through its Biomerieux, Inc. division, will supply its specialized diagnostic platforms and consumables, such as the VITEK, BioFire,...
This is a firm-fixed-price delivery order awarded by the Veterans Integrated Service Network 8 (VISN 8), a division of the U.S. Department of Veterans Affairs (VA), to Biomerieux Inc. through its Biomerieux, Inc. division. The contract, valued at $49,050.24, is for the provision of microbial identification and susceptibility testing services. This order is part of a larger Blanket Purchase Agreement (BPA) held by Biomerieux with the VA, which allows the agency to efficiently procure the...
This is a firm-fixed-price delivery order awarded by the Veterans Integrated Service Network 2 (VISN 2) of the U.S. Department of Veterans Affairs to Biomerieux Inc., a global leader in in vitro diagnostics, through its Biomerieux, Inc. division. The $132,650.04 contract is for bacterial identification and susceptibility testing services, which supports infectious disease testing and pathogen detection across VA healthcare operations. Biomerieux will provide its proprietary VITEK, BioFire, and...
This federal contract award, valued at $14,992.34, was issued by the Defense Health Agency to Biomerieux Inc., a global leader in in vitro diagnostics and microbiological testing solutions. The contract is a firm-fixed-price purchase order for the provision of various reagents and E-test kits, which are specialized diagnostic products for infectious disease testing and pathogen detection. The contract does not have a set-aside designation, indicating that Biomerieux Inc. is likely considered a...

This firm-fixed-price purchase order was awarded by the Defense Health Agency (DHA) to Biomerieux Inc., a global leader in in vitro diagnostics. The contract, valued at $11,258.96, is for the provision of Biomerieux supplies and services, including its proprietary VITEK, BioFire, and VIDAS diagnostic platforms and associated reagents and test kits. Biomerieux, through its Biomerieux, Inc. division, has been a long-standing supplier of clinical diagnostic equipment and consumables to various federal agencies, supporting their infectious disease testing and pathogen detection needs. This contract does not involve a set-aside designation, as Biomerieux is often the sole source provider for its specialized technologies. The award is associated with Biomerieux's existing federal supply schedule contract and blanket purchase agreements, which facilitate ongoing procurement of its diagnostic solutions by government healthcare operations, such as the Department of Veterans Affairs and Indian Health Service.

Generated 11/1/24, 9:19 AM